Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

C3_DLBCL_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions HLP_C3_DLBCL	1538
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C83.3 Hospital discharge: ICD-9 — 2000B Cause of death: ICD-10 — C83.3 Cause of death: ICD-9 — 2000B Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 9680 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	1538
4. Check minimum number of events None	1538
5. Include endpoints HLP_C3_DLBCL	1538
6. Filter based on genotype QC (FinnGen only)	1538

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC
Control conditions: not HLP_C3_DLBCL

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_DLBCL_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!HLP_C3_DLBCL
SEX
INCLUDE	HLP_C3_DLBCL
PRE_CONDITIONS
CONDITIONS	HLP_C3_DLBCL
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C833
HD_ICD_9	2000B
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C833
COD_ICD_9	2000B
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	9680
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1538	679	859
Unadjusted period prevalence (%)	0.31	0.23	0.38
Median age at first event (years)	67.80	66.58	68.77

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1413: Matched controls
14129

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN4BD

NOMESCO Finland

Extensive body CT

41.1

323.0

689

320

L03AA02

ATC

filgrastim; parenteral

2677.6

323.0

507

A04AA02

ATC

granisetron; systemic, transdermal

2210.6

323.0

330

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

323.0

629

M04AA01

ATC

allopurinol; systemic

12.2

323.0

769

1256

XW000

NOMESCO Finland

Bone marrow biopsy

49.6

323.0

494

151

A04AA01

ATC

ondansetron; systemic, rectal

60.7

323.0

430

101

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1162.1

323.0

1225

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

5530.6

323.0

412

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6785.1

323.0

474

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

323.0

1308

A03FA01

ATC

metoclopramide; systemic, rectal

32.3

323.0

915

759

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

323.0

321

L03AA13

ATC

pegfilgrastim; parenteral

+∞

323.0

555

WW500

NOMESCO Finland

Blood transfusion

50.1

316.4

383

104

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

304.4

281

JN4AD

NOMESCO Finland

Body CT examination

27.1

275.9

391

196

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

255.1

237

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

252.8

235

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

696.5

243.8

234

H02AB02

ATC

dexamethasone; systemic

67.2

241.3

277

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

234.0

218

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

227.3

212

D70.82

ICD-10 Finland

Drug-induced neutropenia

325.3

222.3

220

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

35.6

217.4

284

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

217.4

203

ZX120

NOMESCO Finland

Intravenous

12.0

212.8

424

486

H02AB06

ATC

prednisolone; systemic

6.3

212.6

1074

4710

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

15.3

201.5

352

299

1XC02

NOMESCO Finland

135.2

197.3

208

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

192.6

194.3

199

A49.9

ICD-10 Finland

Bacterial infection, unspecified

9.1

191.4

454

701

JN6AD

NOMESCO Finland

CT of torso and neck

112.0

187.9

202

WF003

NOMESCO Finland

Adjuvant radiotherapy

688.0

187.3

181

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

183.4

172

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

5.6

179.1

697

2092

N02AA05

ATC

oxycodone; systemic

7.6

179.1

485

909

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

35.3

177.6

232

WF002

NOMESCO Finland

Radical radiotherapy

281.1

172.7

173

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

+∞

168.1

158

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

257.2

158.7

160

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

146.4

138

PJA10

NOMESCO Finland

Exploration of lymph nodes

141.6

144.3

152

XX3DW

NOMESCO Finland

Time consuming IT work

11.3

138.8

277

297

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

497.7

138.7

136

A02BC02

ATC

pantoprazole; systemic

4.9

137.7

1164

6897

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

256.4

137.6

139

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

97.9

136.1

149

R50.9

ICD-10 Finland

Fever, unspecified

6.2

132.1

408

866

Z51.5

ICD-10 Finland

Palliative care

20.7

130.5

199

111

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

121.6

115

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

120.5

114

ZX112

NOMESCO Finland

Subcutaneous

58.6

117.3

138

C61

ICD-10 Finland

Malignant neoplasm of prostate

401.4

113.1

112

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

113.0

107

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

39.4

109.4

139

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

107.7

102

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

103.3

876

4565

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

350.2

97.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

18.5

96.9

153

ZX070

NOMESCO Finland

Intensity modified radiotherapy

946.9

91.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.7

88.7

345

905

WF004

NOMESCO Finland

Palliative radiotherapy

878.9

85.5

WZC30

NOMESCO Finland

Teaching

5.2

85.0

294

677

H02AB07

ATC

prednisone; oral

4.1

81.9

371

1119

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

26.8

81.8

114

J05AB11

ATC

valaciclovir; oral

4.5

80.0

323

870

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

79.9

L01CB01

ATC

etoposide; systemic

+∞

78.9

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

76.7

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

76.7

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

76.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

8.3

74.9

175

236

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

88.1

74.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

73.6

130

Kela drug reimbursment

Malignant tumour

+∞

72.5

B01AB05

ATC

enoxaparin; parenteral

3.0

72.2

568

2586

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

71.4

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

9.7

71.3

151

172

JN4CD

NOMESCO Finland

Very extensive body CT

14.4

70.9

123

B01AB10

ATC

tinzaparin; parenteral

7.4

70.8

179

272

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

16.1

70.1

116

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

69.3

212

Kela drug reimbursment

Gout

11.9

68.7

130

119

D70.89

ICD-10 Finland

Neutropenic splenomegaly

37.0

67.8

J01MA12

ATC

levofloxacin; systemic

3.4

67.7

395

1441

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

667.5

65.4

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

64.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.9

62.8

187

353

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

61.8

463

1994

ZX090

NOMESCO Finland

Other technic of radiotherapy

320.9

60.8

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.1

58.9

200

439

116

Kela drug reimbursment

Prostate cancer

+∞

58.7

B72

ICPC

Hodgkin Lymphoma

+∞

57.7

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

56.6

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

55.6

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

81.0

55.4

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

32.9

54.8

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

281.2

53.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

12.0

52.4

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

52.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

50.3

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

50.3

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

50.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

258.8

49.4

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

49.2

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.6

48.3

247

791

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

48.2

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.5

47.7

149

295

A41.9

ICD-10 Finland

Sepsis, unspecified

7.1

47.4

121

184

TAB00

NOMESCO Finland

Lumbar puncture

6.3

46.8

131

226

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

46.7

387

1723

115

Kela drug reimbursment

Breast cancer

+∞

46.1

D64.9

ICD-10 Finland

Anaemia, unspecified

3.5

45.9

242

791

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

461.7

45.5

N02BE01

ATC

paracetamol; systemic, rectal

3.0

45.5

1251

10204

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

44.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.5

43.7

440

2173

A79

ICPC

Malignancy NOS

118.7

43.0

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

42.9

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.1

41.9

119

209

WW409

NOMESCO Finland

Other aferesis

419.1

41.3

ZX080

NOMESCO Finland

Image guided radiotherapy

419.1

41.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.5

41.2

210

665

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

40.8

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.8

40.8

144

326

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.6

40.1

122

233

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

39.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

+∞

39.8

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

38.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

8.5

38.4

107

TPX15

NOMESCO Finland

Removal of vascular injection port

137.0

37.9

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

9.6

37.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

37.0

314

1390

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

15.6

36.4

TGC00

NOMESCO Finland

Bronchial lavation

6.7

36.0

151

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.7

36.0

167

488

J05AB01

ATC

aciclovir; systemic

2.5

35.8

336

1570

HA1AA

NOMESCO Finland

X-ray mammography

7.7

35.8

116

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

35.6

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

35.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

7.2

35.0

127

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

97.5

34.9

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

33.1

34.6

A04AA55

ATC

palonosetron, combinations; systemic

+∞

34.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

12.4

33.6

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

33.5

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

33.5

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

33.5

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

33.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

11.5

33.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

33.0

484

2785

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

334.4

33.0

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

173.9

32.8

A07AA02

ATC

nystatin; oral

3.8

32.7

146

412

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

50.0

32.6

9680/3-C62.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of testis, NOS

+∞

32.4

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

32.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.2

32.2

187

648

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

35.1

32.0

D69.5

ICD-10 Finland

Secondary thrombocytopenia

44.4

31.9

H02AB09

ATC

hydrocortisone; systemic

8.1

31.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

31.9

465

2661

L02AE02

ATC

leuprorelin; implant, parenteral

31.6

30.4

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

30.3

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

11.8

30.3

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

19.3

29.7

WX110

NOMESCO Finland

Local anesthesy

1.9

29.2

903

6795

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

11.2

28.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

28.8

153

496

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

105.5

28.7

Z51.0

ICD-10 Finland

Radiotherapy session

153.0

28.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

28.7

417

2360

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

28.6

343

1784

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

28.2

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

28.2

KFC00

NOMESCO Finland

Unilateral orchiectomy

27.8

28.1

C03CA01

ATC

furosemide; systemic

2.0

28.0

522

3258

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

286.7

27.8

Y77

ICPC

Malignant neoplasm prostate

286.7

27.8

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

10.5

27.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

48.2

27.5

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

35.8

27.5

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

35.8

27.5

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

275.9

26.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

26.5

148

496

KA1FN

NOMESCO Finland

Isotope renography

29.8

26.4

ZX108

NOMESCO Finland

Inhalation

21.6

26.1

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

26.1

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

26.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

26.1

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

26.1

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.0

26.1

126

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

25.9

663

4587

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.9

25.7

183

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

25.6

199

824

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

49.2

24.3

3AA13

NOMESCO Finland

+∞

24.0

L02BB03

ATC

bicalutamide; oral

+∞

24.0

E83.50

ICD-10 Finland

Hypercalcemia

10.3

23.9

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

68.6

23.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

23.8

257

1260

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

31.6

23.7

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

31.6

23.7

J01MA14

ATC

moxifloxacin; systemic

2.8

23.7

161

613

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

7.0

23.2

GD1AD

NOMESCO Finland

Thorax CT examination

4.3

23.0

215

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

23.0

9680/3-C17.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of small intestine, NOS

+∞

23.0

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

23.3

22.6

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

21.1

22.6

JFB00

NOMESCO Finland

Partial resection of small intestine

8.5

22.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

+∞

21.9

ZX131

NOMESCO Finland

Intrathecal

+∞

21.9

ED1AA

NOMESCO Finland

Mandipular X-ray examination

18.7

21.8

J01DB01

ATC

cefalexin; oral

1.8

21.4

1095

9189

WX882

NOMESCO Finland

High dependency care

5.1

21.4

142

R4190

NOMESCO Finland

Nutritional therapy

6.7

21.1

WX002

NOMESCO Finland

Sedation and analgesia

2.0

21.0

315

1772

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

28.5

21.0

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

10.8

20.9

127

Kela drug reimbursment

Transplant complication

9.8

20.9

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

20.9

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

20.9

A04AD12

ATC

aprepitant; systemic

+∞

20.9

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

21.8

20.8

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

212.8

20.6

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

111.6

20.6

AAA10

NOMESCO Finland

Biopsy through craniotomy

111.6

20.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.6

20.4

282

R4110

NOMESCO Finland

Physiotherapy

1.9

20.1

367

2217

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

17.6

20.0

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

58.3

19.9

WW200

NOMESCO Finland

Immunization

4.8

19.8

145

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

19.8

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

+∞

19.8

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

19.8

9680/3-C42.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of spleen

+∞

19.8

9680/3-C49.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck

+∞

19.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.1

19.8

128

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

8.8

19.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.3

19.7

120

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

29.4

19.7

HAC20

NOMESCO Finland

Total mastectomy

106.5

19.6

C50.99

ICD-10 Finland

Breast, unspecified

202.6

19.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

19.4

538

3712

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.0

19.2

128

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

5.5

19.2

107

WX402

NOMESCO Finland

General anaesthesia

2.3

19.0

198

950

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

6.8

19.0

JMA10

NOMESCO Finland

Transabdominal total splenectomy

34.8

18.9

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

18.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

18.8

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

18.8

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

18.8

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.1

18.8

187

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.8

18.7

136

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

18.7

152

643

L02BG04

ATC

letrozole; oral

24.0

18.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

101.3

18.6

TGD00

NOMESCO Finland

Needle biopsy of lung

38.9

18.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

192.3

18.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.7

18.4

128

494

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

18.4

123

463

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

30.5

18.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

18.1

250

1355

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

20.3

17.8

WW402

NOMESCO Finland

Leucoferesis

+∞

17.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

17.7

445

2961

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

12.6

17.6

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

29.2

17.4

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

42.5

17.3

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

50.6

17.0

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.9

16.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

16.8

151

673

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

16.7

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

16.7

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

16.7

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

16.7

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

16.7

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

16.7

TQW99

NOMESCO Finland

Other minor procedure on skin

3.6

16.6

214

1CX01

NOMESCO Finland

91.1

16.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

91.1

16.6

EMA10

NOMESCO Finland

Biopsy of tonsil

27.9

16.5

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

11.3

16.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.5

16.3

B02.9

ICD-10 Finland

Zoster without complication

2.7

16.2

112

431

A06AH03

ATC

naloxegol; oral

21.2

16.0

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

15.6

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

15.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

15.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

15.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.5

15.4

127

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

5.4

15.0

N02AX02

ATC

tramadol; systemic, rectal

1.6

15.0

573

4231

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

14.9

186

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

14.6

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

14.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

14.6

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

14.6

9680/3-C38.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS

+∞

14.6

1BC01

NOMESCO Finland

+∞

14.6

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

80.9

14.6

A06AD11

ATC

lactulose; oral

1.9

14.6

224

1258

L01AA02

ATC

chlorambucil; oral

151.4

14.5

C90.0

ICD-10 Finland

Multiple myeloma

151.4

14.5

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

151.4

14.5

L57.0

ICD-10 Finland

Actinic keratosis

2.4

14.4

129

573

ZXA00

NOMESCO Finland

Right side

1.7

14.3

387

2601

N03AX16

ATC

pregabalin; oral

1.7

14.2

316

2008

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

42.9

14.1

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.9

14.1

WX704

NOMESCO Finland

Intubation

2.7

13.9

358

N05CF01

ATC

zopiclone; oral

1.6

13.8

451

3184

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

13.6

259

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

75.8

13.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

13.6

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

13.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

13.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

13.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

13.6

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

13.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.4

13.5

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

34.4

13.5

Z52.89

ICD-10 Finland

Donor of other organ or tissue

141.2

13.5

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

141.2

13.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

141.2

13.5

UJF32

NOMESCO Finland

Coloscopy

1.7

13.3

349

2317

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

6.2

13.2

A07AA09

ATC

vancomycin; oral

6.9

13.2

R11

ICD-10 Finland

Nausea and vomiting

2.4

13.1

111

478

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

8.9

13.0

JAH01

NOMESCO Finland

Laparoscopy

3.6

12.8

167

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.2

12.8

117

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.4

12.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

70.5

12.6

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

32.3

12.6

ENA10

NOMESCO Finland

Biopsy of pharynx

32.3

12.6

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

32.3

12.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

8.3

12.6

L01BC06

ATC

capecitabine; oral

+∞

12.5

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

12.5

JN4DD

NOMESCO Finland

Scout CT scan of torso

+∞

12.5

9680/3-C49.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip

+∞

12.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

12.5

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

12.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

12.5

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

12.5

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.0

12.5

248

WF099

NOMESCO Finland

Other radiotherapy

131.0

12.4

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.6

12.3

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

4.0

12.2

123

J94.8

ICD-10 Finland

Other specified pleural conditions

5.5

12.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.5

12.0

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

11.1

12.0

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

13.5

11.9

R06AE07

ATC

cetirizine; oral

1.5

11.9

496

3685

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

11.9

360

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.2

11.9

ZZR00

NOMESCO Finland

Flap of skin

10.6

11.8

SPAT1153

SPAT

Removal of sutures

1.6

11.7

436

3148

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

30.3

11.6

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.8

11.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.7

11.6

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

65.5

11.6

L02BA01

ATC

tamoxifen; oral

65.5

11.6

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

11.5

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

11.5

9680/3-C30.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasal cavity

+∞

11.5

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

11.5

9680/3-C17.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of ileum

+∞

11.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

11.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

11.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

11.5

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

11.5

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

11.5

JFB30

NOMESCO Finland

Right hemicolectomy

7.5

11.4

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

120.9

11.4

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

7.9

11.4

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

15.2

11.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

11.3

191

GEA00

NOMESCO Finland

Mediastinoscopy

17.2

11.2

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

17.2

11.2

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

20.2

11.1

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

10.1

11.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

14.0

11.0

WX892

NOMESCO Finland

Monitored bed care

2.2

10.9

119

579

B03XA02

ATC

darbepoetin alfa; parenteral

5.1

10.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

10.8

325

2221

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.4

10.8

381

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

10.7

236

1484

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.7

10.7

286

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.7

10.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

110.7

10.4

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

110.7

10.4

9680/3-C49.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS

+∞

10.4

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

10.4

L02BX02

ATC

degarelix; parenteral

+∞

10.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

10.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

10.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

10.4

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

+∞

10.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

9680/3-C17.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of duodenum

+∞

10.4

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

+∞

10.4

AA1AD

NOMESCO Finland

CT of head and brain

1.6

10.3

356

2514

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

18.9

10.3

UKC02

NOMESCO Finland

Cystoscopy

1.7

10.2

214

1324

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

7.0

10.1

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

14.7

10.0

ZX121

NOMESCO Finland

Central venous catheter

40.3

10.0

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

40.3

10.0

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

40.3

10.0

N03AX14

ATC

levetiracetam; systemic

3.6

10.0

126

B01AB04

ATC

dalteparin; parenteral

2.7

9.9

264

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

16.8

9.9

B02

ICPC

Lymph gland(s) enlarged/painful

12.3

9.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.4

9.8

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

26.2

9.8

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.8

9.8

222

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.9

9.6

ZXC95

NOMESCO Finland

Use of surgical navigator

6.4

9.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

9.5

175

G04BE03

ATC

sildenafil; oral

9.1

9.5

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

7.2

9.5

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

100.6

9.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

100.6

9.4

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

30.2

9.4

L01BB05

ATC

fludarabine; systemic

+∞

9.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

9.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

9.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

9.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

9.4

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

9.4

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

9.4

9680/3-C07.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of parotid gland

+∞

9.4

1DB01

NOMESCO Finland

+∞

9.4

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

+∞

9.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

5.4

9.4

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

9.4

133

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

9.3

243

1596

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

9.1

247

A41.8

ICD-10 Finland

Other specified sepsis

4.1

9.1

JAH00

NOMESCO Finland

Laparotomy

3.9

9.0

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

9.1

9.0

J02AC03

ATC

voriconazole; systemic

36.9

9.0

CKA10

NOMESCO Finland

Biopsy of vitreous body

36.9

9.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

9.0

188

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

8.9

176

C10AA07

ATC

rosuvastatin; oral

0.6

8.9

178

2674

R50.8

ICD-10 Finland

Other specified fever

12.6

8.9

WX720

NOMESCO Finland

Own respiration

2.7

8.8

214

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

8.7

217

1405

TK800

NOMESCO Finland

Hemodialysis

3.6

8.7

109

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.2

8.6

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

11.6

8.6

J01MA02

ATC

ciprofloxacin; systemic

1.4

8.6

493

3854

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.8

8.6

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

16.4

8.6

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

10.1

8.5

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

27.7

8.5

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

27.7

8.5

C50

ICD-10 Finland

Malignant neoplasm of breast

90.5

8.4

XX1AD

NOMESCO Finland

Other CT-examination

90.5

8.4

Z94.1

ICD-10 Finland

Heart transplant status

12.8

8.4

9680/3-C48.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of retroperitoneum

+∞

8.3

C82.7

ICD-10 Finland

Other types of follicular lymphoma

+∞

8.3

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

8.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

+∞

8.3

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

+∞

8.3

9680/3-C11.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS

+∞

8.3

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

8.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

8.3

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

8.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

8.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

8.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

8.3

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

8.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

8.3

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

8.3

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

8.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

8.3

1AA09

NOMESCO Finland

+∞

8.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

8.3

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

8.3

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

+∞

8.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

8.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

8.3

JAH21

NOMESCO Finland

Staging laparoscopy

+∞

8.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

8.3

9680/3-C49.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax

+∞

8.3

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

8.3

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

8.3

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

8.6

8.3

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

5.9

8.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.8

8.3

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

10.8

8.3

WX199

NOMESCO Finland

Other local analgesia

3.1

8.2

147

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

8.2

191

1214

L04AD01

ATC

ciclosporin; systemic

4.3

8.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

8.2

108

571

ZXC96

NOMESCO Finland

Robot assisted procedure

7.6

8.2

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

8.2

235

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.1

8.2

J01CA04

ATC

amoxicillin; systemic

1.4

8.1

992

8827

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

17.3

8.1

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

22.1

8.0

B74

ICPC

Malignant neoplasm blood other

22.1

8.0

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

7.9

440

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

13.1

7.9

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

6.1

7.8

ZXC40

NOMESCO Finland

Use of ultrasound

8.5

7.8

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

8.5

7.8

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.9

7.8

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.1

7.8

131

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

45.2

7.7

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

45.2

7.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

7.7

355

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

7.7

331

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.6

7.7

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

18.4

7.6

ZXA05

NOMESCO Finland

Left side

1.5

7.6

333

2459

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

25.1

7.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

25.1

7.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.4

7.5

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

7.5

405

L04AA01

ATC

[U] ciclosporin; systemic

4.1

7.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

7.4

136

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.4

7.3

9680/3-C49.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder

+∞

7.3

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

V03AF03

ATC

calcium folinate; systemic

+∞

7.3

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

7.3

390

Kela drug reimbursment

Ibrutinib

+∞

7.3

128

Kela drug reimbursment

Cancers of female genital organs

+∞

7.3

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

7.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

7.3

L02BB04

ATC

enzalutamide; oral

+∞

7.3

9680/3-C49.6

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS

+∞

7.3

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

+∞

7.3

L01XE27

ATC

[U] ibrutinib; oral

+∞

7.3

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

7.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

7.3

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

7.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

7.3

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

+∞

7.3

9680/3-C41.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints

+∞

7.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

7.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

7.3

N74

ICPC

Malignant neoplasm nervous system

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

7.3

9680/3-C49.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen

+∞

7.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

7.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

7.3

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.9

7.3

C07AB07

ATC

bisoprolol; oral

1.4

7.3

672

5653

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

7.2

425

3311

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

7.2

432

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

15.8

7.2

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

15.8

7.2

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

15.8

7.2

RS220

NOMESCO Finland

4.4

7.1

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

30.1

7.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

7.1

540

4393

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

12.1

7.1

R53

ICD-10 Finland

Malaise and fatigue

1.5

7.0

246

1729

S18

ICPC

Laceration/cut

1.4

7.0

515

4164

A02BC01

ATC

omeprazole; systemic

1.4

7.0

355

2694

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.9

6.9

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

7.6

6.9

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.8

6.9

KA3EB

NOMESCO Finland

Antegrade pyelography

13.8

6.9

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.4

6.8

C09AA05

ATC

ramipril; oral

1.4

6.8

364

2784

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

11.0

6.8

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.1

6.8

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

16.8

6.7

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

16.8

6.7

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

6.7

317

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

7.2

6.7

L04AA06

ATC

mycophenolic acid; systemic

3.7

6.7

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.9

6.7

Z51.88

ICD-10 Finland

Other specified medical care

3.2

6.6

101

B03XA01

ATC

erythropoietin; parenteral

5.9

6.6

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

6.6

295

2180

EMB10

NOMESCO Finland

Tonsillectomy

2.7

6.6

164

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

6.6

400

3127

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

6.5

162

1045

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

10.1

6.5

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.2

6.5

103

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

6.5

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

70.1

6.4

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

70.1

6.4

B73

ICPC

Leukaemia

70.1

6.4

D73.9

ICD-10 Finland

Disease of spleen, unspecified

70.1

6.4

D38.50

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of maxillary sinus

70.1

6.4

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

70.1

6.4

A21

ICPC

Risk factor for malignancy

70.1

6.4

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.4

6.4

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

6.4

426

3380

G04CA02

ATC

tamsulosin; oral

1.4

6.4

332

2523

Z94.0

ICD-10 Finland

Kidney transplant status

4.9

6.4

B02

ICD-10 Finland

Zoster [herpes zoster]

2.4

6.3

217

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.5

6.3

KBV00

NOMESCO Finland

Insertion of stent into ureter

9.3

6.3

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

18.1

6.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

6.3

177

1182

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

6.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

6.3

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

+∞

6.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

6.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

6.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

6.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

6.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

6.3

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

+∞

6.3

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

6.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

6.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

6.3

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

6.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

6.3

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

6.3

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

6.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

6.3

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

6.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

6.3

9680/3-C06.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mouth, NOS

+∞

6.3

X76

ICPC

Malignant neoplasm breast female

+∞

6.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.3

L01AX03

ATC

temozolomide; systemic

+∞

6.3

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

6.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

6.3

1CA02

NOMESCO Finland

+∞

6.3

EBA10

NOMESCO Finland

Surgical removal of tooth

1.8

6.2

104

600

KA3GB

NOMESCO Finland

Retrograde pyelography

26.8

6.2

Z94.4

ICD-10 Finland

Liver transplant status

26.8

6.2

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.8

6.2

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.8

6.1

R18

ICD-10 Finland

Ascites

4.0

6.1

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.6

6.1

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

10.1

6.0

A28

ICPC

Limited function/disability NOS

1.5

6.0

200

1387

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026493) Urate [Moles/volume] in Serum or Plasma

1024

3385

7.06

314.18

6.7

2.5

umol/l

1003.1

6554.3

6.91

986

2880

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

343

259.39

307.65

1.3

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

342

169

25.74

307.65

1.6

1.4

—

(3045142) Bone marrow Pathology biopsy report

341

51.88

307.65

1.5

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

237

60.73

307.65

2.1

2.3

14.8

13.7

0.23

102

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1079

1294

25.59

307.65

8.1

2.8

u/l

304.4

237.8

9.23

1049

1204

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

261

123

25.35

307.65

3.1

2.3

u/ml

9209.4

372.5

1.47

(3011412) CD3 cells [#/volume] in Blood

289

54.52

307.65

2.4

2.0

e9/l

1.0

1.2

0.62

206

(3017143) Hepatitis C virus Ab [Presence] in Serum

764

916

15.59

307.65

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

523

789

9.53

307.65

4.2

2.1

g/l

8.3

10.9

30.64

503

719

(46235355) HIV 1 and 2 tests - Meaningful Use set

812

1220

12.98

307.65

1.5

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

774

988

14.76

307.65

1.5

—

(4035726)

645

355

30.57

307.65

1.7

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

236

66.19

307.65

2.2

2.5

—

(40768795) Lymph node Pathology biopsy report

368

185.74

307.65

1.4

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

170

20.79

307.65

5.8

4.4

iu/ml

5579.5

567.9

0.48

(21494815) CD4 cells/100 lymphocytes in Specimen

205

48.12

307.65

2.3

1.9

31.2

49.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

689

544

22.13

307.65

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

183

39.06

294.50

2.5

1.6

e6/l

496.1

510.7

0.06

153

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

176

38.09

281.48

2.5

1.6

e9/l

0.2

0.19

153

(42870588) Differential panel, method unspecified - Blood

1058

3979

6.32

268.68

10.4

5.4

—

(3022096) Basophils/100 leukocytes in Blood

1231

5332

7.56

264.44

10.8

5.5

0.7

0.58

1204

4900

(3019069) Monocytes/100 leukocytes in Blood

1242

5504

7.53

257.30

11.5

5.8

9.9

8.9

16.20

1215

5070

(3006504) Eosinophils/100 leukocytes in Blood

1236

5482

7.39

254.85

11.0

5.5

2.6

3.0

5.21

1209

5027

(3001604) Monocytes [#/volume] in Blood

1281

5900

8.01

252.10

10.2

5.3

e9/l

0.6

0.06

1190

5025

(3006315) Basophils [#/volume] in Blood

1283

5938

8.00

250.44

10.2

5.3

e9/l

0.0

13.28

1192

5067

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

235

186

14.73

248.07

1.4

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

1241

5606

7.29

247.86

11.4

5.6

24.7

26.9

8.53

1215

5134

(3017181) Myelocytes/100 leukocytes in Blood

477

943

6.88

245.41

5.9

3.7

1.5

0.7

4.89

302

213

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1273

5926

7.66

244.30

16.2

3.9

umol/l

9.9

12.3

16.92

1252

5523

(3019198) Lymphocytes [#/volume] in Blood

1284

6034

7.83

243.46

10.4

5.4

e9/l

1.6

1.8

8.08

1204

5231

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

157

33.51

242.28

2.9

1.4

e6/l

418.8

837.8

2.86

(3013115) Eosinophils [#/volume] in Blood

1292

6132

7.92

241.39

11.1

5.5

e9/l

0.2

18.32

1206

5320

(3018010) Neutrophils/100 leukocytes in Blood

1217

5555

6.71

235.19

10.1

5.5

58.2

57.9

0.24

1192

5118

(3013650) Neutrophils [#/volume] in Blood by Automated count

1322

6543

8.27

231.26

27.6

6.3

e9/l

3.6

4.4

33.60

1249

5622

(21494814) CD8 cells/100 lymphocytes in Specimen

126

68.53

230.25

2.0

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

647

1786

5.53

229.78

8.4

2.5

mmol/l

0.8

9.09

627

1631

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

98.23

226.98

2.1

3.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

210

162

14.85

224.50

1.4

u/ml

115.7

114.6

0.05

(3028026) IgM [Mass/volume] in Serum or Plasma

374

635

7.46

221.46

3.4

1.4

g/l

1.2

0.14

353

575

(3004809) Band form neutrophils/100 leukocytes in Blood

198

141

15.97

221.34

4.6

3.0

1.9

1.7

0.15

167

102

(40765096) Chromosome analysis panel by Banding

115

62.07

206.62

1.3

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

232

243

11.07

203.42

2.4

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

227

231

11.36

203.09

2.4

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

136

28.59

199.73

3.6

2.2

33.9

42.7

2.06

(3024561) Albumin [Mass/volume] in Serum or Plasma

1116

5178

5.21

197.81

9.8

3.7

g/l

33.1

35.4

29.60

1079

4756

(3002179) Metamyelocytes/100 leukocytes in Blood

410

868

6.08

192.91

5.6

3.6

1.0

0.6

1.98

202

155

(3021440) Promyelocytes/100 leukocytes in Blood

418

905

5.97

191.91

6.0

3.8

0.2

0.1

5.49

275

193

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

187

168

12.53

181.38

2.4

1.4

—

(3023368) Bacteria identified in Blood by Culture

849

3452

4.26

173.00

9.1

4.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

532

1560

4.68

168.51

3.1

2.1

1.8

0.04

500

1356

(3023520) Reticulocytes [#/volume] in Blood

447

1174

4.96

161.95

3.4

2.2

e9/l

69.3

70.0

0.14

388

912

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

174

182

10.65

151.70

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

165

160

11.43

151.64

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

197

247

9.00

149.67

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

70.27

146.82

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

513

1617

4.26

144.99

8.1

4.9

mmol/l

1.0

0.30

495

1479

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

353

840

5.16

142.63

2.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

317

693

5.50

141.17

2.0

1.4

ug/l

7.4

3.6

0.60

219

522

(3044640) Blood type and Crossmatch panel - Blood

785

3366

3.72

140.54

4.3

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

181

10.02

137.24

2.0

1.3

—

(3025159) Blasts/100 leukocytes in Blood

353

866

4.99

137.17

5.8

3.9

0.1

0.6

0.46

211

169

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1126

6249

3.99

132.27

14.2

5.4

mmol/l

1.2

2.88

938

5257

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

156

169

10.16

132.26

1.3

1.2

u/ml

284.0

279.7

0.04

111

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

146

10.94

131.05

2.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

113

15.97

129.22

1.7

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1052

5665

3.71

127.57

12.6

5.0

mmol/l

1.2

1.34

1012

4996

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

26.18

127.48

4.8

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

994

5174

3.60

127.04

7.5

3.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

832

3943

3.42

122.55

7.9

2.0

mmol/l

2.3

2.4

1.48

777

3245

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

191

293

7.30

121.41

1.4

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

351

949

4.50

119.63

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

145

10.36

119.43

1.9

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

124

112

11.95

119.04

2.2

1.5

—

(40768804) Tissue Pathology biopsy report

790

3709

3.32

116.65

2.5

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

116

105

11.87

111.11

2.3

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

131

142

9.99

110.71

2.0

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

111

11.43

110.17

5.0

3.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

593

2423

3.36

108.87

9.7

4.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

110

12.14

107.11

2.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

160

9.08

105.13

2.0

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

211

413

5.76

104.82

2.3

3.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

360

1097

3.98

103.16

2.2

1.6

g/l

62.7

66.9

14.43

341

982

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

217

7.61

101.42

1.6

1.4

—

(3018418) pH of Serum or Plasma

747

3612

3.08

101.03

9.5

3.2

7.4

1.57

194

620

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

558

2297

3.24

99.72

5.4

2.2

mmol/l

2.5

6.25

537

1960

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

100

12.51

99.59

1.4

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1350

9294

4.70

98.49

21.4

5.4

u/l

84.5

77.2

7.09

1326

8556

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

598

2620

3.10

95.18

4.2

2.2

—

(40758558) Short blood count panel - Blood

614

2755

3.05

93.33

22.1

4.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

30.64

89.40

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

517

2149

3.12

89.32

3.0

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

25.22

89.26

3.1

1.2

—

(3032080) INR in Blood by Coagulation assay

935

5375

2.89

87.88

11.1

10.6

inr

1.2

1.4

3.99

251

1510

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

155

267

6.34

87.52

1.6

1.2

e6/l

18.5

38.8

0.44

136

219

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

155

267

6.34

87.52

1.7

1.3

e6/l

847.1

964.8

0.06

138

227

(3044290) Cell count panel - Cerebral spinal fluid

144

232

6.74

86.80

1.5

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

102

10.19

85.03

4.2

3.0

57.5

55.9

0.18

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

12.10

83.23

2.6

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

12.11

82.34

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

19.60

81.75

1.5

1.0

—

(44790048)

101

120

8.94

79.26

1.9

1.3

—

(44790049)

101

120

8.94

79.26

1.9

1.3

—

(44790047)

101

120

8.94

79.26

1.9

1.4

—

(44806118)

101

120

8.94

79.26

1.9

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

211

529

4.46

77.54

2.6

1.7

ug/l

3.9

1.7

0.79

192

464

(3021589) Normoblasts [#/volume] in Blood

889

5224

2.66

75.89

19.8

8.7

e9/l

0.0

0.96

771

4250

(3033658) Prothrombin time (PT) actual/Normal

585

2853

2.70

72.30

6.0

3.5

85.4

85.1

0.11

573

2776

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

12.79

72.25

2.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

12.79

72.25

2.3

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1286

9264

3.37

71.85

7.5

4.2

mm/h

17.6

12.7

17.63

1240

8492

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

11.54

71.44

2.2

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

16.39

70.37

1.8

2.3

u/ml

7156.0

6647.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

463

2031

2.83

70.04

2.9

1.3

g/l

2.0

2.7

12.14

387

1149

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

136

257

5.71

69.48

1.9

u/ml

325.8

119.8

0.74

203

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

9.99

68.84

2.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

9.76

67.66

2.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

9.76

67.66

2.6

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

9.76

67.66

2.6

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

452

1995

2.79

67.20

3.0

1.9

29.2

29.9

1.66

439

1926

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

137

271

5.45

66.55

1.6

1.2

mmol/l

3.8

3.9

0.57

129

249

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

373

1509

2.94

65.06

2.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

372

1515

2.92

63.99

2.7

1.7

—

(3002256) Pathology report gross observation

262

872

3.42

63.65

1.3

1.1

—

(3042936) Bacteria identified in Isolate by Culture

398

1708

2.79

61.82

2.1

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

38.94

61.60

1.3

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

100

158

6.70

61.13

6.2

6.6

mg/l

11.6

12.0

0.37

145

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

16.98

60.98

2.9

1.2

—

(3037756) Immunofixation for Serum or Plasma

121

236

5.48

59.60

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

153

6.70

59.37

2.0

2.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1084

7473

2.53

59.33

9.1

4.3

mmol/l

6.7

6.9

1.59

1057

6990

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

16.64

59.18

2.9

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

16.64

59.18

2.9

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

109

196

5.91

58.55

7.9

3.2

58.5

0.00

109

196

(3016018) Differential panel - Cerebral spinal fluid

111

7.75

57.63

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

158

397

4.32

57.39

3.4

2.9

u/ml

0.4

0.3

0.13

235

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

13.23

57.36

2.9

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

13.23

57.36

2.9

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

13.23

57.36

2.9

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

13.23

57.36

2.9

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

142

332

4.61

56.53

1.6

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

152

377

4.36

56.13

1.6

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

105

191

5.83

55.69

5.6

3.1

e9/l

3.6

4.4

2.64

105

191

(3031040) Bacteria [#/volume] in Urine by Automated count

1121

8079

2.43

51.83

5.9

4.5

e6/l

2061.6

2023.0

0.01

126

(3030467) Casts [#/volume] in Urine by Automated count

606

3424

2.27

50.22

4.1

3.0

e6/l

0.5

0.4

0.28

497

2586

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

11.66

50.19

1.3

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

9.84

49.73

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

532

2869

2.31

49.06

1.6

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

294

1205

2.78

48.81

4.2

2.4

umol/l

8.6

8.4

0.06

260

1044

(3002582) Erythrocytes [#/volume] in Urine

637

3728

2.21

47.87

4.3

3.1

e6/l

47.8

92.3

1.09

530

2862

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

110

7.02

47.80

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

22.36

47.35

2.0

1.0

—

(36304419) Bacteria [Presence] in Urine

581

3290

2.23

47.25

4.1

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

176

5.56

47.22

1.3

1.2

miu/ml

175.4

184.8

0.05

(21494434) Karyotype in Bone marrow

103

7.07

45.62

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

700

4366

2.11

43.52

4.0

3.1

ng/l

2019.5

1482.9

2.32

648

3728

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

6.68

43.28

4.0

2.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

208

761

3.00

42.25

1.8

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

9.09

42.09

4.0

1.8

—

(3018095) Leukocytes [#/volume] in Urine

692

4361

2.07

41.19

5.0

3.5

e6/l

183.5

114.1

0.35

553

3098

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

150

457

3.53

41.17

1.7

1.4

g/l

0.7

0.4

0.73

134

390

(3020779) Urea [Moles/volume] in Serum or Plasma

265

1117

2.66

41.16

9.8

6.3

mmol/l

10.1

10.9

0.90

258

1054

(40768806) Pleura Pathology biopsy report

7.26

40.87

1.6

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

542

3.31

40.85

1.9

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

542

3.31

40.85

1.9

1.4

g/l

3.7

3.9

0.69

128

392

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

542

3.31

40.85

1.9

1.4

g/l

7.7

7.5

0.48

127

406

(3026782) Osmolality of Urine

450

2416

2.22

40.64

3.5

2.6

mosm/kgh2o

538.0

547.8

0.47

409

2021

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

137

403

3.63

39.63

1.7

1.3

g/l

0.1

0.0

0.43

131

370

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

175

609

3.11

38.67

1.5

1.6

g/l

1.8

1.5

2.57

140

520

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

505

3.30

38.21

2.0

1.4

g/l

3.7

3.1

5.67

128

399

(3025941) Bacteria identified in Stool by Culture

168

583

3.11

37.26

1.4

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

337

1667

2.31

36.63

2.5

2.6

21.7

23.0

0.76

298

1395

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

236

992

2.63

36.60

12.5

3.0

mmol/l

1.2

0.99

230

828

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

613

3834

2.00

35.96

2.9

2.3

u/l

50.8

58.3

2.52

558

3486

(3000850) Epithelial cells [#/volume] in Urine

464

2628

2.10

35.80

3.4

2.4

e6/l

3.8

5.0

3.21

426

2279

(3022948) Iron [Moles/volume] in Serum or Plasma

373

1946

2.21

35.52

2.5

2.4

umol/l

11.8

12.9

2.23

346

1777

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

151

512

3.16

34.77

1.7

1.4

g/l

8.9

10.5

4.48

138

430

(3019832) Treponema pallidum Ab [Presence] in Serum

138

445

3.31

34.52

1.4

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

348

1789

2.22

34.23

2.5

g/l

2.1

2.3

8.30

325

1648

(3028433) Virus identified in Specimen by Culture

10.23

33.69

1.3

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

124

381

3.45

33.47

1.7

1.3

g/l

0.0

0.50

118

349

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

123

376

3.47

33.47

1.7

1.3

g/l

0.0

0.00

118

348

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

128

407

3.34

32.72

2.0

1.5

mg/l

32.8

48.4

0.56

329

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

225

975

2.53

32.57

2.4

1.9

g/l

0.2

1.64

206

878

(40758292) HTLV I+II Ab panel - Serum

63.12

32.15

1.5

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

127

408

3.30

31.92

2.0

1.5

mg/l

60.1

45.7

0.61

330

(3001964) Herpes simplex virus Ag [Presence] in Specimen

11.61

31.87

1.6

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

124

393

3.34

31.86

2.0

1.4

ratio

17.1

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

525

3227

1.95

31.44

2.1

2.3

mg/l

3.5

3.0

3.56

450

2703

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

131

434

3.21

31.30

1.7

1.3

g/l

34.4

37.5

5.15

122

365

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

104

298

3.67

31.19

1.8

2.0

mg/l

10.9

12.0

0.74

269

(3012441) Differential panel - Pleural fluid

104

5.76

31.13

1.7

1.5

—

(3023410) Appearance of Cerebral spinal fluid

116

5.43

30.75

1.5

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

15.25

30.57

1.7

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

563

3569

1.91

30.55

6.8

2.6

u/l

34.4

41.8

0.79

537

3376

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

196

823

2.58

30.20

6.3

3.5

mmol/l

2.1

1.8

0.48

167

586

(3009343) pH of Capillary blood

200

855

2.54

29.66

6.2

3.5

7.4

1.51

106

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

7.77

29.40

1.5

1.2

65.5

56.6

—

(3026008) Bacteria identified in Urine by Culture

589

3829

1.87

29.26

3.7

3.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

201

870

2.51

29.02

6.2

3.5

kpa

5.0

5.2

1.73

191

795

(3000991) Gas panel - Venous blood

228

1046

2.39

28.97

9.0

6.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

15.87

28.87

1.6

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

11.80

28.32

1.8

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

262

1291

2.24

28.12

7.4

3.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

160

4.47

27.59

1.1

—

(3000494) Fungus identified in Specimen by Culture

275

1394

2.18

27.47

1.9

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

294

3.49

27.40

2.2

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

742

5258

1.79

27.22

4.9

4.0

ng/l

51.0

62.4

0.21

643

3909

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

348

1935

2.03

27.20

3.9

2.9

e6/l

1.9

2.5

0.73

220

1058

(3037467) Urinalysis macro (dipstick) panel - Urine

1073

8517

1.86

26.61

5.7

4.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

117

5.02

26.39

1.5

1.6

u/ml

3.2

41.9

0.60

112

(3000093) Morphology [Interpretation] in Blood Narrative

115

5.02

25.91

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

5.47

25.05

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

217

1036

2.27

24.96

2.0

1.7

nmol/l

373.5

361.4

0.41

208

922

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

139

4.53

24.93

1.4

1.8

u/ml

23.9

45.2

0.63

126

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

363

2110

1.94

24.71

3.6

2.7

e6/l

1.0

1.4

0.90

234

1228

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1387

12152

2.44

24.67

42.9

13.8

mg/l

25.7

24.8

0.55

1308

9514

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

49.19

24.33

1.6

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

287

1563

2.03

23.43

9.7

5.6

mmol/l

103.9

104.2

0.31

277

1517

(3022313) Gas panel - Capillary blood

151

631

2.54

23.32

7.2

3.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

110

4.86

23.25

1.1

—

(3002032) Base excess in Venous blood by calculation

246

1272

2.11

23.08

6.4

3.2

mmol/l

1.8

2.0

0.42

201

1016

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

204

984

2.24

22.80

2.2

2.3

u/l

33.8

38.9

0.43

178

813

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

409

2531

1.84

22.68

2.0

1.7

mg/l

1.9

1.3

1.25

325

1963

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

127

499

2.68

22.20

1.8

1.9

u/l

43.3

39.1

1.02

112

421

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

132

535

2.61

21.68

7.8

3.8

mmol/l

25.6

24.6

3.12

126

491

(3021447) Carbon dioxide [Partial pressure] in Venous blood

241

1278

2.05

21.01

6.6

3.1

kpa

5.7

5.8

1.98

234

1231

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

141

4.16

20.99

2.2

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

5.01

20.94

1.3

1.8

u/l

0.9

2521.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

142

4.13

20.79

2.2

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

130

534

2.57

20.77

3.0

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

288

3.14

20.76

3.8

2.1

87.7

88.9

0.17

274

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

242

3.34

20.69

1.5

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

165

3.87

20.67

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

134

4.22

20.66

1.7

1.5

e6/l

2165.3

1839.4

0.25

(3003396) Base excess in Arterial blood by calculation

268

1485

1.97

20.63

10.4

6.3

mmol/l

1.3

0.04

209

1137

(3005988) Vibrio sp identified in Specimen by Organism specific culture

143

4.10

20.60

2.2

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

264

3.22

20.49

2.0

1.3

—

(3012501) Base excess in Blood by calculation

259

3.25

20.47

5.4

4.4

mmol/l

2.8

0.02

174

(3010375) cycloSPORINE [Mass/volume] in Blood

7.27

20.39

33.8

24.1

ug/l

106.0

127.6

0.83

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

146

4.02

20.04

2.2

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

420

2708

1.76

19.89

4.6

4.0

ng/l

721.7

479.6

0.23

370

2280

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

4.33

19.83

1.5

e6/l

34054.4

89043.1

0.48

(3027801) Oxygen [Partial pressure] in Arterial blood

266

1489

1.95

19.82

10.3

6.3

kpa

12.2

11.4

1.91

252

1422

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

266

1489

1.95

19.82

10.3

6.3

kpa

4.9

5.1

1.60

249

1424

(3000012) Reticulocyte production index

5.38

19.72

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

148

3.96

19.67

2.2

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

149

3.93

19.49

2.2

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

211

1097

2.07

19.33

8.1

5.8

mmol/l

1.7

1.5

1.49

201

1058

(3016502) Oxygen saturation in Arterial blood

244

1343

1.97

19.05

11.0

6.5

96.1

95.0

3.09

233

1293

(3019225) pH of Specimen

237

1297

1.98

18.80

8.5

3.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

6.14

18.61

1.1

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

13.00

18.57

1.5

1.1

u/ml

27.3

19.5

0.58

(3019060) Gas panel - Arterial blood

181

902

2.14

18.50

9.1

4.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.32

18.01

1.6

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

4.04

17.79

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

6.22

17.69

1.7

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

6.22

17.69

1.7

1.3

—

(1616796) Gas panel - Central venous blood

268

3.01

17.48

4.0

3.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

280

2.96

17.36

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

280

2.96

17.36

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.71

17.30

1.0

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

223

1228

1.95

17.30

11.8

6.7

g/l

110.3

122.5

13.23

213

1187

(3010421) pH of Blood

314

2.84

17.28

5.5

4.1

7.4

4.43

257

(3007853) Bacteria identified in Skin by Aerobe culture

248

1416

1.90

17.26

1.9

1.8

—

(40761536) Microorganisms panel - Urine sediment

183

954

2.04

16.55

4.9

3.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.17

16.51

1.6

1.2

—

(3023419) Bacteria identified in Sputum by Culture

188

3.34

16.38

1.8

2.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

641

4801

1.57

16.15

3.0

2.8

ug/l

493.0

141.8

10.26

586

4346

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

12.43

16.04

1.2

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

7.87

15.31

1.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

8.73

15.03

4.2

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

250

2.89

14.67

4.0

2.2

233.0

198.2

1.82

236

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

111

498

2.32

14.61

2.2

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.17

14.61

1.0

1.1

—

(3024471) HLA-A [Type]

6.96

14.44

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

258

2.79

13.85

1.6

2.7

umol/l

31.9

38.0

0.69

220

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

10.81

13.76

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

892

7339

1.51

13.74

4.4

3.0

u/l

70.5

51.4

3.60

824

6664

(3024932) HLA-DR beta [Type]

6.85

13.60

1.3

1.1

—

(40768797) Stomach Pathology biopsy report

265

1654

1.73

13.51

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

648

5014

1.51

13.28

2.5

2.2

nmol/l

76.5

78.5

1.07

594

4355

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.91

13.17

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

6.97

13.15

1.9

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

10.09

13.14

1.1

mmol/l

2.3

0.9

—

(3017732) Neutrophils [#/volume] in Blood

150

790

2.00

13.12

2.5

3.1

e9/l

3.7

4.2

2.01

107

556

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

126

624

2.11

13.02

8.5

3.6

mmol/l

24.2

24.3

0.20

116

552

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

261

2.68

12.48

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

160

878

1.92

12.41

12.7

6.4

mmol/l

24.8

24.5

0.42

149

822

(3052592) Norovirus Ag [Presence] in Stool

7.80

12.30

1.9

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.66

12.14

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

363

2.39

12.05

4.5

3.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

198

2.90

11.99

1.4

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

5.07

11.96

1.2

1.1

ng/l

2930.8

54.0

0.99

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.99

11.87

1.3

1.1

ug/l

1.5

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

12.09

11.75

1.0

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

12.09

11.75

1.0

1.2

107.4

94.6

—

(40757373) Influenza virus identified in Isolate

6.13

11.67

1.6

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

23.08

11.57

5.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

4.23

11.55

1.2

1.1

mg/l

93.3

34.3

2.13

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.56

11.44

1.1

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.56

11.44

1.1

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.69

11.43

1.1

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

110

3.52

11.30

1.4

1.2

g/l

0.3

0.4

1.05

(3027135) IgG subclass 1 [Mass/volume] in Serum

110

3.52

11.30

1.4

1.2

g/l

4.8

7.0

2.66

(4062490)

110

3.52

11.30

1.5

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

110

3.52

11.30

1.4

1.2

g/l

1.8

2.9

2.46

(3035880) pH of Pleural fluid

4.49

11.22

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

4.78

11.20

5.7

3.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

558

4301

1.47

11.11

2.4

2.2

u/l

172.4

241.7

1.04

525

4026

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

4.86

10.97

2.4

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

1115

9819

1.49

10.80

46.2

16.5

14.7

13.7

67.11

1102

9554

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

223

1409

1.68

10.73

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

21.62

10.68

1.0

1.3

—

(3022145) Colonoscopy Study observation

191

1159

1.74

10.65

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

141

781

1.89

10.62

10.0

7.8

94.4

93.2

3.12

141

776

(3045788) Cell count panel - Pleural fluid

110

3.42

10.58

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

348

2.31

10.44

1.6

iu/ml

0.1

0.69

(3013512) EKG study

518

3976

1.46

10.38

5.4

4.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

170

2.88

10.28

1.6

1.8

g/l

0.6

1.0

1.92

133

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

122

653

1.94

10.18

16.9

9.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

109

576

1.96

9.45

2.8

3.1

pmol/l

4.3

4.5

1.42

490

(3024891) Influenza virus A+B Ag [Presence] in Specimen

277

2.37

9.21

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

206

1326

1.64

9.17

4.1

3.1

ng/l

276.2

222.4

0.95

195

1229

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

167

1018

1.72

9.13

4.5

3.6

ng/l

85.7

91.9

0.38

140

868

(4027681)

4.23

8.93

1.4

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

173

2.71

8.85

1.6

1.3

iu/l

28.5

27.0

0.10

149

(3019550) Sodium [Moles/volume] in Serum or Plasma

1390

13013

1.71

8.77

42.3

16.6

mmol/l

139.2

139.8

13.71

1370

12626

(40767503) Oxygen content in Capillary blood by calculation

271

2.34

8.74

3.4

2.4

14.4

16.7

3.10

146

(3044889) 12 lead EKG panel

1020

8985

1.40

8.66

5.4

4.1

—

(3020393) Adenovirus Ag [Presence] in Stool

16.38

8.55

1.8

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

279

1964

1.51

8.39

26.4

29.3

inr

1.4

0.06

278

(3010937) Rubella virus Ab [Presence] in Serum

+∞

8.34

1.1

0.0

—

(3020891) Body temperature

103

558

1.91

8.32

6.1

4.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.12

8.27

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1390

13051

1.68

8.18

42.9

16.7

mmol/l

4.0

0.27

1368

12644

(40768793) Breast Pathology biopsy report

3.61

8.14

1.3

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

113

636

1.84

8.11

9.6

8.1

mmol/l

24.1

24.4

0.49

106

582

(3035637) Corticotropin [Mass/volume] in Plasma

3.34

8.09

1.3

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

6.55

8.07

1.7

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1258

11561

1.48

8.05

35.1

12.7

ml/min/173m2

76.3

75.5

0.75

1159

9274

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.67

8.02

1.1

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

169

1071

1.65

7.98

6.5

2.6

kpa

4.9

4.5

0.98

162

1028

(3051611) Lipemic interference index of Serum or Plasma

115

3.00

7.95

4.9

3.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

342

2.13

7.95

1.4

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

716

6006

1.36

7.94

6.2

5.0

estimate

0.0

0.00

200

1061

(3035350) Ketones [Presence] in Urine by Test strip

715

6000

1.36

7.89

4.7

3.7

estimate

0.0

0.00

196

1055

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

178

2.57

7.87

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.88

7.86

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

358

2.09

7.81

3.2

3.1

mmol/l

23.9

25.0

1.18

313

(3047181) Lactate [Moles/volume] in Blood

420

2.01

7.80

15.2

5.7

mmol/l

1.5

1.3

1.50

375

(3029937) Albumin [Presence] in Urine by Test strip

428

3312

1.40

7.77

5.3

4.1

estimate

0.0

0.50

181

1018

(3014765) Yersinia sp identified in Stool by Organism specific culture

346

2.10

7.72

1.4

1.1

—

(40768441) Liver Pathology biopsy report

4.36

7.69

1.1

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

348

2.09

7.61

1.4

1.1

—

(3049717) Cytology report of Urine Cyto stain

453

1.95

7.56

2.7

1.9

—

(3048879) Bone marrow aspiration report

4.89

7.41

1.5

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.63

7.41

1.1

miu/ml

1087.8

1543.0

0.83

(3009261) Glucose [Presence] in Urine by Test strip

719

6080

1.34

7.36

4.8

3.8

estimate

0.0

0.80

188

1021

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

7.30

1.0

0.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.74

7.17

2.5

2.6

—

(3046861) Legionella sp Ag [Presence] in Urine

20.12

7.13

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

258

3506

0.68

7.13

1.7

1.6

mmol/l

1.5

1.4

2.26

211

2896

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

101

3.01

7.10

1.1

u/l

75.8

52.0

0.52

(3009542) Hematocrit [Volume Fraction] of Blood

1169

10681

1.39

7.00

36.9

15.3

36.5

39.4

17.65

711

6850

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.61

6.94

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

13.84

6.89

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.21

6.86

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

492

1.86

6.79

1.4

1.2

—

(3008295) Osmolality of Serum or Plasma

126

2.74

6.79

1.4

mosm/kgh2o

271.4

276.3

0.62

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

352

2.01

6.68

1.2

1.3

—

17.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

105

2.89

6.65

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.59

6.60

1.2

1.0

u/l

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

140

2.61

6.56

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1383

13086

1.56

6.48

25.2

9.4

u/l

26.8

25.9

0.97

1362

12476

(3021901) Oxygen saturation in Capillary blood

254

2.17

6.47

3.0

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1149

12338

0.73

6.46

4.4

4.8

mmol/l

4.4

4.5

3.34

1032

11255

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.95

6.44

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

130

2.65

6.41

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1138

12230

0.73

6.34

4.3

4.8

mmol/l

1.3

1.4

11.33

1011

11070

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

198

2.31

6.32

3.9

3.3

—

(40758358) Immune stain study

+∞

6.25

1.0

0.0

—

(40768800) Prostate Pathology biopsy report

2.86

6.11

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

4.32

6.03

1.9

—

(3037121) Protein [Mass/volume] in Urine

423

1.86

6.02

2.9

2.5

g/l

0.9

0.3

0.60

138

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

270

2.08

5.93

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

1338

12615

1.47

5.92

32.5

13.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

426

1.85

5.90

5.5

3.9

mmol/l

3.8

3.9

0.85

396

(3018572) Chloride [Moles/volume] in Blood

296

2.00

5.65

19.7

6.3

mmol/l

104.4

105.4

0.59

271

(3039000) Anion gap in Blood

296

2.00

5.65

19.7

6.3

mmol/l

10.8

11.0

0.16

271

(3021960) Folate [Moles/volume] in Serum or Plasma

413

3321

1.33

5.61

1.5

nmol/l

19.6

20.4

0.48

348

2756

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

146

2.43

5.57

3.8

3.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

328

1.93

5.46

1.4

1.6

g/l

0.2

0.05

317

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

128

834

1.58

5.43

2.1

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

174

2.27

5.35

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

303

1.95

5.31

2.6

2.0

g/l

118.7

132.9

2.89

227

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1191

12635

0.75

5.22

4.8

5.4

mmol/l

2.6

2.10

1053

11470

(40763480) Human metapneumovirus Ag [Presence] in Specimen

+∞

5.21

1.4

0.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1376

13102

1.48

5.20

45.6

16.0

umol/l

84.8

81.3

1.90

1376

13097

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

567

1.68

5.15

13.4

4.4

1.6

1.7

0.62

540

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

104

653

1.64

5.14

4.5

3.3

51.1

48.1

0.63

104

641

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

714

0.45

5.13

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

560

1.68

5.12

13.8

4.5

0.9

0.07

534

(3019309) Folate [Moles/volume] in Red Blood Cells

350

2782

1.33

5.09

1.8

nmol/l

1233.4

1168.9

0.53

268

2076

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

134

2.42

5.07

1.2

u/ml

3.7

7.1

0.87

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.30

5.03

3.0

4.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.24

4.90

1.2

1.1

u/l

31.5

19.0

0.53

(3017446) Testosterone [Moles/volume] in Serum or Plasma

119

782

1.57

4.88

2.4

2.2

nmol/l

12.3

14.8

2.76

111

677

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

114

2.48

4.72

1.1

1.2

—

(40768443) Skin Pathology biopsy report

474

1.70

4.66

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

275

1.92

4.63

1.1

—

(3016750) Collection duration of Urine

2.78

4.62

2.6

2.0

min

517.8

498.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

227

2.01

4.58

1.1

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

14.05

4.58

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.22

4.56

1.0

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

542

4632

1.26

4.44

5.1

4.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

375

3064

1.30

4.40

4.5

3.4

—

(3003181) Sodium [Moles/volume] in Urine

238

1.96

4.38

1.7

1.3

mmol/l

64.9

65.0

0.01

191

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.97

4.29

1.2

1.1

u/l

302.7

86.6

0.52

(3042733) HLA Ab [Presence] in Serum

3.89

4.26

5.6

4.2

—

(3037522) Nuclear Ab [Titer] in Serum

204

1532

1.38

4.25

1.3

titre

795.5

561.1

0.53

357

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.63

4.21

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.63

4.21

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

141

2.22

4.13

1.2

u/ml

5.0

3.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

324

1.79

4.09

3.0

3.2

nmol/l

1.0

0.8

0.83

250

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.10

4.09

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.77

4.09

3.0

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1114

11823

0.79

3.99

4.1

4.3

mmol/l

1.4

1.3

2.30

993

10599

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

6.46

3.98

1.6

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.30

3.86

1.8

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.30

3.86

1.8

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.30

3.86

1.7

1.0

—

(3019977) pH of Arterial blood

2.62

3.81

3.7

2.3

7.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.75

3.76

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.02

3.69

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

116

2.26

3.65

2.8

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.18

3.50

1.7

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

140

1021

1.41

3.48

3.3

2.4

ml/min/173m2

57.3

63.2

0.78

420

(4281824)

2.85

3.36

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.74

3.34

5.6

5.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

315

1.71

3.32

2.0

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.93

3.30

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

8.60

3.26

1.0

—

(3024731) MCV [Entitic volume]

1399

13538

1.37

3.13

56.5

20.1

92.2

91.5

6.61

1382

13260

(3035941) MCH [Entitic mass]

1399

13539

1.37

3.12

56.4

20.0

30.5

0.92

1382

13262

(3026361) Erythrocytes [#/volume] in Blood

1399

13540

1.37

3.11

56.7

20.1

e12/l

4.1

4.5

108.70

1365

13018

(3010813) Leukocytes [#/volume] in Blood

1399

13541

1.37

3.10

56.7

20.2

e9/l

6.4

6.8

4.24

1366

13023

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1129

11877

0.81

3.10

5.6

6.5

mmol/mol

40.7

40.8

0.16

1006

10879

(3000963) Hemoglobin [Mass/volume] in Blood

1399

13543

1.37

3.08

56.9

20.3

g/l

122.9

136.0

127.77

1381

13261

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.25

3.06

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.02

3.05

1.0

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

355

3000

1.24

3.05

1.7

pmol/l

40636524.2

31176174.8

0.09

283

2441

(3004451) EKG impression Narrative

2.52

3.04

1.4

1.3

—

(3007461) Platelets [#/volume] in Blood

1398

13536

1.36

3.04

56.8

20.1

e9/l

212.9

242.4

42.17

1367

13077

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

481

0.51

2.89

1.4

1.5

—

(4306422)

137

1.99

2.81

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.46

2.79

1.7

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.46

2.79

1.0

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.24

2.77

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

8.36

2.75

6.2

5.8

g/mol

427.2

37.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

8.36

2.75

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

8.36

2.75

1.6

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

2.73

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.02

2.70

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

296

1.64

2.68

1.1

titre

87.1

83.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.91

2.58

1.1

—

(3017704) Immunofixation for Urine

2.24

2.54

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.83

2.47

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

4.39

2.47

8.4

1.1

—

41.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

138

1.90

2.42

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

117

1.98

2.41

2.8

2.4

755.2

606.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.01

2.40

1.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

3.35

2.39

1.1

2.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

153

1922

0.77

2.38

1.2

u/ml

14.6

14.4

0.01

718

(3034770) Mitochondria Ab [Titer] in Serum

306

1.59

2.38

1.1

1.2

—

1898.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.76

2.37

4.0

2.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

322

1.57

2.37

1.7

1.5

ug/g

205.1

297.9

2.93

188

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.51

2.36

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

249

0.40

2.35

1.4

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.27

2.34

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

664

1.39

2.33

1.2

u/ml

317.7

252.3

0.14

607

(3033799) Differential panel - Peritoneal fluid

3.23

2.31

1.0

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

2.39

2.29

1.3

umol/l

4.6

5.2

—

(3047189) Immunofixation for 24 hour Urine

2.70

2.28

1.7

1.1

—

(21494755) Public health laboratory ask at order entry panel

626

0.63

2.23

1.2

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

156

1245

1.28

2.20

2.2

2.1

ug/g

224.4

167.5

0.53

130

969

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1252

0.74

2.11

1.4

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

628

5744

1.16

2.11

2.0

2.1

pmol/l

90.6

93.5

0.82

366

2901

(3045424) Erythrocytes [Presence] in Urine

183

1.71

2.09

1.6

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

585

5331

1.16

2.05

4.6

3.9

ug/l

3.3

2.1

0.82

515

4755

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.23

2.01

1.6

1.4

u/l

17.1

8.8

—

(40768446) Kidney Pathology biopsy report

2.64

2.01

1.3

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

488

0.61

2.00

1.3

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.29

1.98

1.5

1.3

—

(1002224) Polysomnography panel

387

0.56

1.98

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

172

1.70

1.94

3.0

2.2

—

(3044927) Protein electrophoresis panel - Urine

173

1.69

1.90

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

570

1.37

1.86

1.2

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

342

3013

1.17

1.84

4.7

3.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.21

1.84

1.2

1.3

u/l

134.6

398.8

0.87

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

1.70

1.82

1.9

2.4

mg/l

27.0

22.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.77

1.79

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

165

1362

1.24

1.78

2.4

2.5

ug/l

13.8

7.8

0.72

131

1182

(4010399)

949

0.74

1.77

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.04

1.75

2.1

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.04

1.75

2.1

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.51

1.74

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

541

0.66

1.73

1.3

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.68

1.72

7.3

7.8

—

(3036603) Volume of Urine

2.14

1.71

1.5

1.3

1726.8

1917.9

—

(40761535) Cells panel - Urine sediment

143

1171

1.24

1.67

4.4

3.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.17

1.66

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

120

1.76

1.62

1.0

u/ml

1.5

2.3

—

(4268621)

1.85

1.62

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.33

1.60

5.5

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.33

1.60

5.5

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

242

1.50

2.0

1.9

iu/l

7.8

4.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

360

1.40

1.48

4.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

668

6245

1.12

1.47

2.8

2.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.51

1.45

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.13

1.44

1.0

—

(3014891) Appearance of Pleural fluid

3.13

1.44

1.6

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.13

1.44

2.2

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

426

4659

0.88

1.43

4.0

mg/mmol

7.9

7.6

0.07

279

2977

(3024928) Oxygen saturation in Venous blood

288

1.44

1.40

9.5

2.7

—

(3016038) Potassium [Moles/volume] in Urine

1.76

1.35

1.5

1.2

mmol/l

23.5

34.9

2.67

(3035320) C reactive protein [Mass/volume] in Body fluid

1.87

1.34

2.0

2.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.14

1.33

1.0

1.5

ug/l

5.9

10.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

221

0.54

1.33

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

113

1.69

1.32

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

966

9258

1.12

1.31

3.9

3.8

pmol/l

15.0

0.09

873

8257

(4146454)

175

0.51

1.29

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.79

1.27

2.7

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.41

1.24

1.2

1.4

—

(3045414) Leukocytes [Presence] in Urine

532

1.29

1.21

1.8

2.0

—

(3014271) Vancomycin [Susceptibility]

1.80

1.21

2.2

2.8

—

(1761868) Lipid panel - Serum or Plasma

346

3794

0.89

1.20

3.0

3.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

507

0.72

1.16

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.06

1.15

7.3

7.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

144

1.54

1.09

1.0

g/l

1.8

1.5

1.27

125

(3012516) Albumin [Mass/volume] in Urine

410

4420

0.90

1.04

3.4

3.2

mg/l

986.1

164.3

1.65

268

2823

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

215

0.60

1.03

1.4

2.0

—

(3025130) Human papilloma virus identified in Specimen

1.84

1.03

1.7

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

700

1.23

1.02

2.4

2.5

—

(3038515) Glucose [Moles/volume] in Venous blood

307

1.34

1.02

4.2

2.9

mmol/l

7.1

7.6

0.64

294

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.65

1.00

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

176

0.57

1.00

1.3

1.9

—

(3034426) Prothrombin time (PT)

2.00

1.00

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

115

1.57

0.99

1.3

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.18

0.98

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.97

0.0

6.4

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.96

0.0

2.4

—

3.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

141

1.50

0.95

1.0

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.23

0.93

1.2

2.1

mmol/l

1.2

—

(3000492) Spirometry study

116

996

1.18

0.92

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.91

0.88

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.91

0.88

7.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.65

0.88

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.65

0.88

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.65

0.88

1.0

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1156

11286

1.10

0.86

4.6

mu/l

4.4

2.1

0.47

1040

10127

(3000330) Specific gravity of Urine by Test strip

698

1.20

0.85

3.6

3.7

—

(3025577) Chromium [Mass/volume] in Blood

111

0.54

0.83

1.5

2.1

ug/l

1.5

1.8

—

(3026470) Cobalt [Mass/volume] in Blood

115

0.52

0.82

1.5

2.0

ug/l

1.7

3.1

—

105

(3008037) Lactate [Moles/volume] in Venous blood

328

1.29

0.82

4.1

2.8

mmol/l

1.6

0.13

315

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.65

0.81

1.4

1.8

nmol/l

16.1

17.5

0.24

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.59

0.78

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.59

0.78

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.59

0.78

1.0

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

314

0.73

0.76

1.3

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.09

0.74

2.6

4.0

—

(3019150) Specific gravity of Urine by Refractometry

302

2804

1.10

0.73

5.1

4.1

kg/l

1.0

1.02

418

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

401

0.77

0.73

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.80

0.72

2.4

1.2

ug/l

12.8

9.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

142

1.41

0.72

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

206

0.68

0.71

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.75

0.71

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

239

0.71

0.69

1.8

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

200

1826

1.11

0.68

14.4

6.9

—

(3017569) Oxygen content in Arterial blood

1.56

0.68

2.2

1.6

—

(4015189)

1.67

0.68

1.0

2.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

302

1.26

0.68

4.5

3.4

mg/l

26.5

28.5

0.16

196

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.58

0.65

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.58

0.65

1.1

1.0

—

(4094501)

360

0.77

0.65

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

181

1981

0.90

0.64

1.2

1.3

iu/ml

60.4

41.3

0.41

616

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

177

0.68

0.63

1.1

1.5

77.0

66.0

—

116

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.50

0.63

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

1195

0.88

0.62

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

358

0.78

0.62

2.0

1.6

e6/l

15017.8

12245.7

0.30

262

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.55

0.62

1.2

1.3

u/l

30.8

31.6

0.03

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

316

2968

1.08

0.60

2.7

ug/l

0.8

0.7

0.67

220

2038

(3004616) Nuclear Ab [Presence] in Serum

162

0.68

0.58

2.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

339

0.79

0.54

1.5

1.7

—

(4024509)

125

1.36

0.53

1.2

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.49

0.53

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.49

0.53

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

397

1.19

0.52

1.6

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

1.43

0.49

11.8

13.2

—

(3009508) Creatinine [Moles/volume] in Urine

434

4529

0.94

0.49

3.2

mmol/l

7.1

7.5

1.21

360

3794

(3011288) Drugs identified in Urine by Screen method

110

1.37

0.48

1.0

3.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.61

0.43

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

113

1.33

0.42

1.1

1.3

—

31.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.38

0.42

1.3

1.5

umol/l

20.1

13.8

2.01

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

52.5

—

(3021788) Differential panel - Synovial fluid

260

0.81

0.40

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.47

0.40

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.40

0.0

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.39

0.0

1.3

—

6.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.37

0.34

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.37

0.34

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.37

0.34

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.37

0.34

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

108

1166

0.92

0.34

1.9

1.7

1.6

0.25

991

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

1.24

0.33

1.1

—

(3011648) Oxygen content in Venous blood

100

1.30

0.33

21.4

1.9

11.9

11.0

0.27

100

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

166

0.78

0.33

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

164

0.79

0.30

1.1

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.27

0.30

1.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

441

4282

1.04

0.30

4.0

3.8

22.4

24.1

1.46

225

2078

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

247

2367

1.05

0.29

1.2

u/ml

2.0

1.9

0.02

627

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.29

0.28

1.0

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.20

0.26

1.6

1.2

nmol/l

112.8

149.3

—

(3027944) Amphetamines [Presence] in Urine

171

0.82

0.26

1.1

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

197

1.17

0.26

2.1

1.6

mu/l

377.9

291.0

0.63

180

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.17

0.24

1.3

1.5

—

(3015183) Erythrocyte sedimentation rate

1.25

0.22

1.0

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

178

0.84

0.22

1.5

1.2

nmol/l

0.8

0.6

0.23

168

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(44806071)

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(36660697) Celiac disease serology panel - Serum

857

1.07

0.21

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.25

0.20

2.0

1.4

g/l

1.0

0.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.0

—

43.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.13

0.18

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

328

1.10

0.18

1.8

1.7

nmol/l

52.4

42.8

1.17

308

(3013139) Helicobacter pylori Ag [Presence] in Stool

783

0.94

0.17

1.2

1.3

—

(44813793)

0.75

0.17

1.0

—

(4211845)

0.71

0.16

3.2

4.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

244

1.11

0.16

1.1

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

477

1.07

0.15

1.1

titre

—

353.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

160

0.87

0.14

1.5

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

1.15

0.13

2.7

2.2

u/field

1.4

2.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

304

0.92

0.13

1.5

1.2

u/ml

2.5

4.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

116

0.86

0.12

1.0

ng/l

44.2

49.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

300

0.93

0.10

1.5

1.2

u/ml

1.5

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

636

0.96

0.10

1.2

iu/ml

157.3

127.6

0.17

244

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

155

0.90

0.09

1.5

1.2

nmol/l

—

(3006462) Nitrate [Presence] in Urine

0.78

0.08

3.2

4.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.08

0.08

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

171

1741

0.98

0.07

4.2

4.9

31.9

32.9

0.51

126

1116

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

382

1.05

0.07

2.0

1.8

—

(3008898) HLA-B27 [Presence]

294

1.06

0.07

1.0

1.1

—

(3024263) Appearance of Synovial fluid

0.83

0.07

1.6

1.7

—

(3028300) Cannabinoids [Presence] in Urine

173

0.92

0.06

1.1

1.9

—

(3027008) Opiates [Presence] in Urine

173

0.92

0.06

1.1

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

384

1.04

0.06

3.2

2.3

ug/min

153.5

87.1

0.43

236

(4034850)

456

0.96

0.06

10.7

10.3

—

(3014051) Protein [Presence] in Urine by Test strip

297

1.04

0.05

2.1

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

171

0.93

0.05

1.1

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1236

12344

1.01

0.02

5.1

5.0

mmol/l

6.0

6.1

0.35

1116

11082

(3032773) Endomysium IgG Ab [Titer] in Serum

1.08

0.02

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

153

1.05

0.01

1.2

1.4

pmol/l

200.9

295.9

1.06

117

(3022621) pH of Urine by Test strip

848

0.99

0.01

3.5

3.2

—

(3003338) MCHC [Mass/volume]

1004

10030

1.00

0.01

50.1

18.3

g/l

331.3

332.4

3.89

994

9947

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

174

0.98

0.00

1.7

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

135

0.96

0.00

1.1

2.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

15.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

7.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.88

0.00

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.91

0.00

1.0

1.3

promille

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.00

0.00

2.1

2.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

10.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.00

0.00

1.8

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.2

—

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

130

1.00

0.00

1.4

12.5

25.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.0

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

357.7

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.95

0.00

1.0

2.6

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_DLBCL_EXALLC – Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers) (C3_DLBCL_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints